Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × atezolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 36 Triple Negative Breast Neoplasms 16 Carcinoma, Transitional Cell 14 Breast Neoplasms 14 Small Cell Lung Carcinoma 12 Urinary Bladder Neoplasms 11 Melanoma 10 Carcinoma, Hepatocellular 9 Neoplasms 8 Carcinoma, Renal Cell 8 Uterine Cervical Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Lymphoma, Follicular 4 Lymphoma 4 Recurrence 3 Leukemia, Myeloid, Acute 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Kidney Neoplasms 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2

Interventions

Paclitaxel 19 pembrolizumab 16 Carboplatin 12 Bevacizumab 7 lenvatinib 6 rucaparib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 Gemcitabine 4 Cisplatin 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Trastuzumab 2 Taxes 2 Radiotherapy, Intensity-Modulated 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03694262 2026-04-13

EndoBARR

Medical College of Wisconsin

Phase 2 Completed

30 enrolled 7 charts

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡